Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.800
-0.110 (-5.76%)
Mar 27, 2026, 1:27 PM EDT - Market open
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 4 analysts that cover Caribou Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $10.75, which forecasts a 497.22% increase in the stock price over the next year. The lowest target is $8.00 and the highest is $13.
Price Target: $10.75 (+497.22%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Caribou Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +622.22% | Mar 9, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +622.22% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $9 | Strong Buy | Maintains | $3 → $9 | +400.00% | Nov 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $5 → $8 | Strong Buy | Maintains | $5 → $8 | +344.44% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +66.67% | Apr 28, 2025 |
Financial Forecast
Revenue This Year
11.34M
from 11.16M
Increased by 1.63%
Revenue Next Year
12.58M
from 11.34M
Increased by 10.93%
EPS This Year
-1.37
from -1.59
EPS Next Year
-1.34
from -1.37
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.6M | 15.8M | |||
| Avg | 11.3M | 12.6M | |||
| Low | 9.8M | 11.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 12.9% | 38.9% | |||
| Avg | 1.6% | 10.9% | |||
| Low | -12.2% | -1.6% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -0.86 | -0.65 |
| Avg | -1.37 | -1.34 |
| Low | -1.70 | -1.70 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.